Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» drug pricing
drug pricing
Aligning drug prices with ICER estimates could save tens of billions of dollars — JAMA paper
Endpoints
Wed, 12/14/22 - 07:35 pm
ICER
Inflation Reduction Act
drug pricing
Pfizer's plan for $110+ Covid-19 vaccines riles up US senators
Endpoints
Wed, 12/14/22 - 10:23 am
Pfizer
COVID-19
vaccines
drug pricing
Senate
On its annual list of price hike offenders, ICER calls out Bausch's Xifaxan, J&J's Invega
Fierce Pharma
Wed, 12/7/22 - 10:10 am
ICER
drug pricing
Bausch Health
Xifaxan
JNJ
Invega
Despite Eye-Popping $3.5 Million Price Tag For Gene Therapy Hemgenix, Budget Impact For Most Payers Will Be Relatively Small
Forbes
Mon, 12/5/22 - 10:48 am
Hemgenix
gene therapy
hemophilia B
drug pricing
CSL
A $3.5M ‘bargain’? CSL’s hemophilia B drug sets new pricing benchmark, as gene therapy costs mount
Medical Marketing and Media
Thu, 12/1/22 - 10:34 am
CSL
Hemgenix
drug pricing
hemophila B
Sanders poised to lead Senate health committee
BioPharma Dive
Mon, 11/28/22 - 10:32 am
drug pricing
Bernie Sanders
Senate
Cost watchdog ICER backs multimillion-dollar price tags for BioMarin, CSL hemophilia gene therapies
Fierce Pharma
Thu, 11/3/22 - 11:02 am
ICER
drug pricing
gene therapy
Biomarin
CSL
Bluebird Bio
hemophilia
Sanofi, Alnylam Q3 Reports Hint at Early Pipeline Impacts from IRA
BioSpace
Mon, 10/31/22 - 04:17 pm
Sanofi
Alnylam
earnings
Inflation Reduction Act
legislation
drug pricing
Alnylam scraps trial in rare eye disorder, blaming drug price reforms
Pharmaphorum
Fri, 10/28/22 - 10:25 am
Alnylam
RNAi
vutrisiran
Stargardt disease
Inflation Reduction Act
drug pricing
ICER on MS drugs: TG's ublituximab not cost effective at the same price as Roche's ocrelizimab
Endpoints
Tue, 10/18/22 - 10:36 am
ICER
MS
multiple sclerosis
drug pricing
ublituximab
TG Therapeutics
President Biden offers another push on drug price savings via executive order
Endpoints
Sun, 10/16/22 - 05:20 pm
drug pricing
Medicare
Joe Biden
Big Pharma Says Drug Prices Reflect R&D Cos, but new study finds no correlation between research and development spending and outlandish drug prices
Wired
Fri, 10/14/22 - 10:18 am
drug pricing
R&D
ALS drug's approval draws cheers from patients, questions from skeptics
NPR
Sun, 10/2/22 - 07:45 pm
ALS
FDA
Amylyx Pharmaceuticals
drug pricing
Relyvrio
New drug price law could help Part D enrollees who can't fill cancer treatments due to costs, White House says
Endpoints
Mon, 09/26/22 - 11:26 pm
Medicare Part D
drug pricing
Inflation Reduction Act
Novo Nordisk, Gilead, BMS and AstraZeneca will feel the most pain from Biden's pricing bill: analysts
Fierce Pharma
Mon, 09/26/22 - 11:25 pm
Inflation Reduction Act
Joe Biden
Novo Nordisk
Gilead Sciences
Bristol Myers Squibb
AstraZeneca
drug pricing
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
Morningstar
Wed, 09/14/22 - 09:31 am
Roche
AstraZeneca
Eli Lilly
R&D
drug pricing
New study reveals the extent to which drugmakers use condition-specific charities to induce spending on costly drugs
Endpoints
Thu, 09/8/22 - 10:41 am
drug pricing
charities
What “Negotiating” With Medicare Means For Drug Makers: A Mixture Of Price Controls And Actual Negotiations
Forbes
Thu, 09/1/22 - 10:40 am
drug pricing
Medicare
Inflation Reduction Act
Patient groups sue feds to crack down on insurer, PBM copay adjustment programs
Fierce Healthcare
Wed, 08/31/22 - 10:37 am
PBMs
copay asssistance programs
drug pricing
HHS
US drug pricing reform in Inflation Reduction Act could harsh pharma's credit, Moody's says
Fierce Pharma
Fri, 08/19/22 - 10:44 am
legislation
Inflation Reduction Act
drug pricing
Big Pharma
Joe Biden
credit
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »